Submitted:
24 August 2025
Posted:
25 August 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. The Objective of the Review
3. The WHO Health System Building Block Framework
4. The COVID-19 Accelerated Vaccination Campaign in Oman across the WHO Health System Building Blocks
4.1. Firstly, Leadership and Governance
4.1.1. Role of Other Core Government Sectors:
4.1.2. Integrating Public Private Partnership
4.1.3. Role of the Community and Volunteers
4.2. Secondly, Service Delivery and Health Care Responsiveness
4.2.1. Evidence for COVID-19 Vaccination
4.2.2. Reporting of Reactions to COVID-19 Vaccination
4.2.3. Reaching out for Foreigners (Non-Arabic Speakers)
4.3. Thirdly, the Health Workforce
4.4. Fourthly, Health Information Systems
4.5. Fifthly, Access to Essential Medicines:
4.6. Sixthly, Financing:
5. Challenges/ Limitations
6. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| WHO | World Health Organization |
| EVM | Effective Vaccine Management |
| MoH | Ministry of Health |
| PHC | Primary Health Care |
| HCWs | Healthcare workers |
References
- World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020?utm_source=chatgpt.com (accessed July 25, 2025).
- Lives saved by COVID --19 vaccines. J Paediatrics Child Health 2022;58:2129–2129. [CrossRef]
- World Health Organization. COVID-19 advice for the public: Getting vaccinated 2024. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/advice?utm_source=chatgpt.com.
- Moghadas SM, Vilches TN, Zhang K, Nourbakhsh S, Sah P, Fitzpatrick MC, et al. Evaluation of COVID-19 vaccination strategies with a delayed second dose. PLoS Biol 2021;19:e3001211. [CrossRef]
- Henry DA, Jones MA, Stehlik P, Glasziou PP. Effectiveness of COVID-19 vaccines: findings from real world studies. Med J Aust 2021;215:149-151.e1. [CrossRef]
- Al-Abri SS, Al-Rawahi B, Abdelhady D, Al-Abaidani I. Effective vaccine management and Oman’s healthcare system’s challenge to maintain high global standards. Journal of Infection and Public Health 2018;11:742–4. [CrossRef]
- Al Wahaibi A, Al Rawahi B, Patel PK, Al Khalili S, Al Maani A, Al-Abri S. COVID-19 disease severity and mortality determinants: A large population-based analysis in Oman. Travel Medicine and Infectious Disease 2021;39:101923. [CrossRef]
- Medical Xpress. Oman launches COVID-19 vaccination campaign 2020.
- Al Khalili S, Al Maani A, Al Wahaibi A, Al Yaquobi F, Al-Jardani A, Al Harthi K, et al. Challenges and Opportunities for Public Health Service in Oman From the COVID-19 Pandemic: Learning Lessons for a Better Future. Front Public Health 2021;9:770946. [CrossRef]
- Al Ghafri T, Al Ajmi F, Anwar H, Al Balushi L, Al Balushi Z, Al Fahdi F, et al. The Experiences and Perceptions of Health-Care Workers During the COVID-19 Pandemic in Muscat, Oman: A Qualitative Study. J Prim Care Community Health 2020;11:2150132720967514. [CrossRef]
- Al Lamki S, Aal Jumaa I, Al Ghafri M, Al Abri Z. Oman: a primary health care case study in the context of the COVID-19 pandemic. World Health Organization 2024. https://iris.who.int/bitstream/handle/10665/376136/9789240088603-eng.pdf?sequence=1 (accessed July 25, 2025).
- Al Rawahi B, Al Wahaibi A, Al Khalili S, Al Balushi AYM, Al-Shehi N, Al Harthi K, et al. The impact of the acceleration of COVID-19 vaccine deployment in two border regions in Oman. IJID Regions 2022;3:265–7. [CrossRef]
- Reuters research. COVID-19 Tracker. Reuters COVID-19 Tracker 2022. https://www.reuters.com/world-coronavirus-tracker-and-maps/graphics/world-coronavirus-tracker-and-maps/countries-and-territories/oman/ (accessed May 22, 2025).
- Al Wahaibi A, Al-Maani A, Alyaquobi F, Al Harthy K, Al-Jardani A, Al Rawahi B, et al. Effects of COVID-19 on mortality: A 5-year population-based study in Oman. International Journal of Infectious Diseases 2021;104:102–7. [CrossRef]
- Khamis F, Al Rashidi B, Al-Zakwani I, Al Wahaibi AH, Al Awaidy ST. Epidemiology of COVID-19 Infection in Oman: Analysis of the First 1304 Cases. Oman Med J 2020;35:e145–e145. [CrossRef]
- Mansour S, Alahmadi M, Mahmoud A, Al-Shamli K, Alhabsi M, Ali W. Geospatial modelling of COVID19 mortality in Oman using geographically weighted Poisson regression GWPR. Sci Rep 2025;15:8138. [CrossRef]
- World Health Organization. Everybody’s Business: Strengthening Health Systems to Improve Health Outcomes-WHO’s Framework for Action. World Health Organization 2007.
- Frenk J. The Global Health System: Strengthening National Health Systems as the Next Step for Global Progress. PLoS Med 2010;7:e1000089. [CrossRef]
- World Health Organization. MONITORING THE BUILDING BLOCKS OF HEALTH SYSTEMS: A HANDBOOK OF INDICATORS AND THEIR MEASUREMENT STRATEGIES. World Health Organization 2020. https://iris.who.int/bitstream/handle/10665/258734/9789241564052-eng.pdf (accessed July 25, 2025).
- Al Ghafri TS, Al Balushi L, Al Balushi Z, Al Hinai F, Al Hasani S, Anwar H, et al. Reporting at Least One Adverse Effect Post-COVID-19 Vaccination From Primary Health Care in Muscat. Cureus 2021. [CrossRef]
- Naik S, Vr S, Mohakud S, Tripathy T. Analysis of COVID-19 Vaccine Adverse Drug Reactions Reported Among Sultan Qaboos University Hospital Staff. Sultan Qaboos University Medical Journal 2024;24:216–20. [CrossRef]
- Hasani SA, Ghafri TA, Al Lawati H, Mohammed J, Al Mukhainai A, Al Ajmi F, et al. The Use of Telephone Consultation in Primary Health Care During COVID-19 Pandemic, Oman: Perceptions from Physicians. J Prim Care Community Health 2020;11:2150132720976480. [CrossRef]
- World Health Organization. WHO collaboration in Oman’s response to COVID-19 2025. https://www.emro.who.int/omn/oman-news/who-collaboration-on-omans-response-to-covid-19.html (accessed July 25, 2025).
- BADR AL SAMAA GROUP OF HOSPITALS & MEDICAL CENTRES. BADR AL SAMAA COMPLETES COVID-19 VACCINATION DRIVE AT NATIONAL MUSEUM 2021. https://al-khoud.badralsamaahospitals.com/news-and-event/67/badr-al-samaa-completes-covid-19-vaccination-drive-at-national-museum?page=9 (accessed July 25, 2025).
- The Arabian Stories. COVID-19 vaccine: Private sector firms in Oman encourage staff to get jab 2021. https://www.thearabianstories.com/2021/05/18/covid-19-vaccine-private-sector-firms-in-oman-encourage-staff-to-get-jab/ (accessed July 25, 2025).
- Arabnews. Oman vaccinates almost 2 million people against COVID-19 2021. https://www.arabnews.com/node/1900826/middle-east (accessed July 25, 2025).
- OERLive. Occidental Oman Contributes $2.5 Million Towards COVID Vaccine Procurement 2021.
- Observer Oman Daily. Oman LNG earmarks RO6 million for COVID-19, Job Security 2020.
- Observer Oman Daily. OCCI donates RO 2 million for job fund, COVID-19 2020.
- Al Awaidy ST, Khatiwada M, Castillo S, Al Siyabi H, Al Siyabi A, Al Mukhaini S, et al. Knowledge, Attitude, and Acceptability of COVID-19 Vaccine in Oman: A Cross-sectional Study. Oman Med J 2022;37:e380. [CrossRef]
- Al Awaidy S, Khamis F, Al Ghafri T, Badahdah A. Support for Mandatory COVID-19 Vaccines for 5- to 11-Year-Old Children: Cross-sectional study of Omani mothers. Sultan Qaboos Univ Med J 2024;24:229–34. [CrossRef]
- Al Siyabi H, Al Mukhaini S, Kanaan M, Al Hatmi S, Al Anqoudi Z, Al Kalbani A, et al. Community Participation Approaches for Effective National COVID-19 Pandemic Preparedness and Response: An Experience From Oman. Front Public Health 2021;8:616763. [CrossRef]
- Samhouri D, Aynsley TR, Hanna P, Frost M, Houssiere V. Risk communication and community engagement capacity in the Eastern Mediterranean Region: a call for action. BMJ Glob Health 2024;7:e008652. [CrossRef]
- Al Manji A, Tahoun M, Chi Amabo F, Alabri M, Mahmoud L, Al Abri B, et al. Contact tracing in the context of COVID-19: a case study from Oman. BMJ Glob Health 2022;7:e008724. [CrossRef]
- Khamis F, Al Mahyijari N, Al Lawati F, Badahdah AM. The Mental Health of Female Physicians and Nurses in Oman during the COVID-19 Pandemic. Oman Med J 2020;35:e203–e203. [CrossRef]
- Large turnout as mass vaccination gets underway at OCEC. Vaccination Campaign at OCEC 2021.
- Mughal F, Khunti K, Mallen CD. The impact of COVID-19 on primary care: Insights from the National Health Service (NHS) and future recommendations. Journal of Family Medicine and Primary Care 2021;10:4345–9. [CrossRef]
- Naik S, Vr S, Mohakud S, Tripathy T. Analysis of COVID-19 Vaccine Adverse Drug Reactions Reported Among Sultan Qaboos University Hospital Staff. Sultan Qaboos University Medical Journal 2024;24:216–20. [CrossRef]
- Said EA, Al-Rubkhi A, Jaju S, Koh CY, Al-Balushi MS, Al-Naamani K, et al. Association of the Magnitude of Anti-SARS-CoV-2 Vaccine Side Effects with Sex, Allergy History, Chronic Diseases, Medication Intake, and SARS-CoV-2 Infection. Vaccines 2024;12:104. [CrossRef]
- Al Busaidi BH, Al Riyami IM, Wazir HB, Al Zakwani IS. Analysis of COVID-19 Vaccine Adverse Drug Reactions Reported Among Sultan Qaboos University Hospital Staff. Sultan Qaboos Univ Med J 2024;24:216–20. [CrossRef]
- Jose J, Rubaie MHA, Ramimy HA, Varughese SS. Pharmacovigilance. Sultan Qaboos University Medical Journal 2021;21:e161-163. [CrossRef]
- Rudolph A, Mitchell J, Barrett J, Sköld H, Taavola H, Erlanson N, et al. Global safety monitoring of COVID-19 vaccines: how pharmacovigilance rose to the challenge. Therapeutic Advances in Drug Safety 2022;13:20420986221118972. [CrossRef]

| WHO Building Blocks | Strengths | Challenges/ Limitations | Lessons learned |
| Leadership and Governance |
|
|
|
| Service Delivery |
|
|
|
| Health Workforce |
|
|
|
| Health Information Systems |
|
|
|
| Access to Essential Medicines (Vaccines & Supplies) |
|
|
|
| Financing |
|
|
|
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).